The Next Frontier of Healthcare: Why Confidential Computing is the Missing Link in AI-Driven Biotech
We stand at the precipice of a medical revolution. Artificial intelligence is no longer a futuristic concept confined to research…
Category: Opinion
Biotech Patents Are Becoming Industrial Policy Again
Biotech investors usually discuss competitiveness in terms of research quality, clinical execution, manufacturing depth, or access to capital. Those still…
The Resurgence of Biotech: Why the Science of Tomorrow is the Investment of Today
As macroeconomic headwinds fade and clinical innovation accelerates, the biotechnology sector is emerging from its prolonged winter to offer generational…